Google eye AI passes one million patients across three countries
TL;DR
- Google's diabetic retinopathy AI has screened over one million patients across India, Thailand and Australia, per a Comment published 23 September in Nature Medicine.
- The three anchor deployments are Aravind Eye Care System in Madurai, Rajavithi Hospital in Bangkok, and Lions Outback Vision at Lions Eye Institute.
- Google licenses the model to Forus Health, AuroLab and Perceptra, targeting six million AI-assisted screenings across India and Thailand over ten years.
Over one million patients have been screened using Google's diabetic retinopathy detection model across health systems in India, Thailand and Australia, according to a Comment published 23 September in Nature Medicine. The three anchor deployments are Aravind Eye Care System in Madurai, Rajavithi Hospital in Bangkok, and Lions Outback Vision at Lions Eye Institute in Western Australia.
Google does not run the screening. The Automated Retinal Disease Assessment (ARDA) is licensed to three commercial operators — Forus Health, AuroLab and Perceptra — with a stated target of six million AI-assisted screenings across India and Thailand over the next ten years, delivered at no cost to patients.
The paper, co-authored by Google researchers with clinical partners at the three anchor sites, frames a decade of joint work as offering "cross-cutting insights that may inform the expansion of healthcare artificial intelligence globally." Two of the clinical-AI researchers we follow posted it the day it went live.
Shared on Bluesky by 2 AI experts
-
Over a million patients were screened for diabetic eye disease as Google scaled its clinical tool across India, Thailand, and Australia. One of the biggest challenges wasn't the model itself; it was sorting out camera o…
View on Bluesky →
Originally reported by nature.com
Read the original article →Original headline: Practical lessons in the global scaling of clinical AI: from one hospital to over a million patients screened - Nature Medicine